When it comes to clinical studies, particularly those examining human abuse potential (HAP), the way participants are selected and recruited is crucial. These studies are designed to evaluate whether a substance, such as a new medication or drug, has the potential to...
Here at Dr. Vince Clinical Research, we have built an ideal clinical research facility for human abuse potential (HAP) that ensures a comfortable and safe environment for study volunteers. As a CRO for HAP trials, our volunteers experience upscale amenities and...
Download our white paper to learn more about the assessment of abuse liability in tobacco and nicotine products. Discover key regulatory requirements, evaluation methodologies and the latest research on addictiveness and potential harm. Authors: Neil Sherwood, PhD,...
Human pain models have been established as effective, cost-efficient tools for evaluating the efficacy of analgesic drugs. Three acute pain models have been most commonly used in recent years: bunionectomy, third molar extraction and abdominoplasty. Each of these...
With over 70,000 annual deaths, fentanyl overdose is the leading cause of death for Americans aged 18-45. In collaboration with Cessation Therapeutics, Dr. Vince Clinical Research (DVCR) led a First-in-Human trial to test a breakthrough anti-fentanyl antibody....
Recent Comments